Influence d’inhibiteurs tyrosine kinase sur la biologie et la survie de cellules de cancer colorectal

Abstract : The aim of the work is to characterize the influence of VEGF signaling , especially autocrine VEGF signaling , the biology and susceptibility / resistance to anticancer drugs of colorectal cancer cells. We wished to characterize the impact of the autocrine VEGF signaling in CRC models with natural resistance to bevacizumab , an anti -VEGF antibody. Although this compound is active in the CRC, a subpopulation of patients do not respond to treatment. Our results show an autocrine regulatory pathway HIF- VEGF- VEGFR in response to prolonged exposure to bevacizumab in bevacizumab resistant cells. If the resistance to the antibody is established, other inhibitos of VEGF pathway remain active (such as small molecule nintedanib ) and can inhibit the mTOR pathway. Autocrine VEGF signaling plays a role in CRC cell survival. In subjects resistant to bevacizumab, it would be interesting to introduce the nintedanib alone or in combination to enhance the angiogenic inhibition. Another combination of targeted agents ( anti-VEGF (R) and anti EGFR) has shown efficacy in preclinical models of CRC. The combination of bevacizumab and a small molecule targeting EGFR (erlotinib) showed greater efficacy than bevacizumab alone in CRC models regardless of KRAS status. Bevacizumab induces activation of the EGFR survival pathway in tumor cells and in endothelial cells associated with the tumor. This activation is decreased with the introduction of erlotinib. The results indicate that the combination of bevacizumab and erlotinib are more active in maintenance therapy than bevacizumab alone, even for patients mutated KRAS . These findings led to the positive Phase III clinical study GERCOR DREAM in metastatic colon cancer.
Document type :
Theses
Complete list of metadatas

Cited literature [271 references]  Display  Hide  Download

https://tel.archives-ouvertes.fr/tel-01194876
Contributor : Abes Star <>
Submitted on : Monday, September 7, 2015 - 5:00:07 PM
Last modification on : Thursday, March 21, 2019 - 12:24:07 PM
Long-term archiving on : Wednesday, April 26, 2017 - 6:30:42 PM

File

va_Mesange_Paul.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-01194876, version 1

Citation

Paul Mésange. Influence d’inhibiteurs tyrosine kinase sur la biologie et la survie de cellules de cancer colorectal. Pharmacologie. Université René Descartes - Paris V, 2014. Français. ⟨NNT : 2014PA05P635⟩. ⟨tel-01194876⟩

Share

Metrics

Record views

758

Files downloads

596